This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Boston Scientific's newly acquired TIVUS™ Intravascular Ultrasound System for Renal Denervation procedures

Ticker(s): BSX, OTSKY, MDT, ReCor Medical

Who's the expert?

Institution: University of Michigan 

  • Interventional Cardiologist and Clinical Scientist at the University of Michigan
  • Manages 100+ patients for Atrial Fibrillation.
  • Research focos in exploring the molecular and cellular response to myocardial stress and its role in cardiac remodeling

Interview Questions
Q1.

Please describe your background and patient setting

Added By: ben_admin
Q2.

How many patients with resistant hypertension do you manage?

Added By: ben_admin
Q3.

Do you plan to utilize RDN systems in practice?

Added By: ben_admin
Q4.

How does the TIVUS system compare to other renal denervation systems on the market?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.